AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 267 filers reported holding AVANOS MED INC in Q3 2021. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $551,000 | -15.1% | 15,151 | +2.2% | 0.02% | -10.0% |
Q1 2021 | $649,000 | +15.1% | 14,830 | +20.7% | 0.02% | +11.1% |
Q4 2020 | $564,000 | +43.1% | 12,287 | +3.6% | 0.02% | +38.5% |
Q3 2020 | $394,000 | +13.2% | 11,861 | +0.1% | 0.01% | +8.3% |
Q2 2020 | $348,000 | +61.1% | 11,849 | +48.0% | 0.01% | +50.0% |
Q1 2020 | $216,000 | – | 8,006 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |